Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, April 17, 2023
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
John Ransom Maintained (UNH) at Strong Buy and Held Target at $630 on, Apr 17th, 2023
John Ransom of Raymond James, Maintained "UnitedHealth Group Incorporated" (UNH) at Strong Buy and Held Target at $630 on, Apr 17th, 2023.
John has made no other calls on UNH in the last 4 months.
There are 4 other peers that have a rating on UNH. Out of the 4 peers that are also analyzing UNH, 1 agrees with John's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Kevin Caliendo of "UBS" Maintained at Hold with Decreased Target to $550 on, Wednesday, January 18th, 2023
These are the ratings of the 3 analyists that currently disagree with John
- Steven Valiquette of "Barclays" Maintained at Buy and Held Target at $565 on, Friday, April 14th, 2023
- Erin Wright of "Morgan Stanley" Maintained at Buy and Held Target at $587 on, Thursday, April 6th, 2023
- Scott Fidel of "Stephens & Co." Reiterated at Buy and Held Target at $605 on, Tuesday, February 28th, 2023
